Area of research
Oncology · Economics and Econometrics
Research interest
Research focused on Nivolumab and Cochrane Library, with related work in Phase (matter), Disease, Interim analysis. Notable publications include 'Statins for the primary prevention of cardiovascular disease', 'Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related...', and 'Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial'.
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF©) and determination of a threshold score for moderate symptoms
Development of symptom-focused outcome measures for advanced and indolent systemic mastocytosis: the AdvSM-SAF and ISM-SAF©
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
Health-related quality of life results from the phase III CheckMate 067 study
Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial
Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study
Multiple Risk Factor Interventions for Primary Prevention of CVD in LMIC: A Cochrane Review
Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries
Promoting patient uptake and adherence in cardiac rehabilitation
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
Reduced dietary salt for the prevention of cardiovascular disease
Huffman and colleagues' response to Abramson and colleagues' article on statins in low risk people
Statins for the primary prevention of cardiovascular disease
Statin Therapy for Primary Prevention of Cardiovascular Disease
FOOD ACQUISITION AND INTRA-HOUSEHOLD CONSUMPTION PATTERNS: A STUDY OF LOW AND MIDDLE INCOME URBAN HOUSEHOLDS IN DELHI, INDIA.
PubMed 2013cited by 9position: middle
Statins Work Just as Well in Women as in Men